Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Zomedica Pharmaceuticals Corp (ZOM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Zomedica Pharma's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.1621 -0.0064    -3.80%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1642
+0.0021
+1.2955%
20:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 3,964,238
  • Bid/Ask: 0.1605 / 0.1642
  • Day's Range: 0.1611 - 0.1700
Zomedica Pharma 0.1621 -0.0064 -3.80%

NYSE:ZOM Financials

 
A brief overview of the NYSE:ZOM financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Zomedica Pharmaceuticals Corp over time.

Zomedica Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 25.19 million compared to USD 18.93 million a year ago. Net loss was USD 34.53 million compared to USD 17.02 million a year ago. Basic loss per share from continuing operations was USD 0.035 compared to USD 0.017 a year ago. Diluted loss per share from continuing operations was USD 0.035 compared to USD 0.017 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ZOM Income Statement

Gross margin TTM 68.76%
Operating margin TTM -125.43%
Net Profit margin TTM -137.1%
Return on Investment TTM -10.62%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 7.34 6.35 6.02 5.48
Gross Profit 5.07 4.36 4.05 3.84
Operating Income -11.39 -5.95 -6.74 -7.51
Net Income -22.41 -0.491 -5.25 -6.38

ZOM Balance Sheet

Quick Ratio MRQ 10.15
Current Ratio MRQ 11.06
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.14%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 253.2 275.05 274.78 279.6
Total Liabilities 13.18 14.17 15.3 16.54
Total Equity 240.02 260.88 259.48 263.06

ZOM Cash Flow Statement

Cash Flow/Share TTM -0.02
Revenue/Share TTM 0.03
Operating Cash Flow  -55.59%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -5.02 -3.03 -3.68 -4.26
Cash From Investing Activities -3.83 -3.12 23.32 -14.79
Cash From Financing Activities
Net Change in Cash -8.83 -6.17 19.6 -19.05
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ZOM Comments

Write your thoughts about Zomedica Pharmaceuticals Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bill Iannelli
Bill Iannelli Mar 01, 2024 3:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
something going on here. Big volunne and daily rise in price .
Reply
1 0
Report
Mark Mallonee
Mark Mallonee Dec 18, 2023 8:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any reason for today’s jump?
Reply
1 0
Report
Murat Öztürk
Murat Öztürk Dec 18, 2023 8:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://finance.yahoo.com/news/zomedica-announces-expansion-market-opportunity-113000281.html
Reply
1 0
Report
Mark Mallonee
Mark Mallonee Dec 18, 2023 8:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Murat Öztürk What is that? I’m not understanding the implication sadly of the article. Do you know what it means?
Reply
0 0
Report
Sean Taylor
Sean Taylor Jan 06, 2023 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes ZOM up we go baby
Reply
8 0
Report
אלכסי קולסניקוב
אלכסי קולסניקוב Jan 06, 2023 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any news why is it going up
Reply
0 0
Report
Sean Taylor
Sean Taylor Jan 06, 2023 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
אלכסי קולסניקוב I believe an upgrade from an investment analyst. I don't have pro https://investing.com to check
Reply
0 0
Report
Jan Achrén
Jan Achrén Jan 06, 2023 6:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Dawson James analyst initiates coverage on Zomedica (ZOM) with a Buy rating and a price target of $6.00. The analyst comments "Our valuation for Zomedica is based on revenue projections out to 2030. We anticipate a reverse stock split in our model. We know the market itself is quite large. We assume the company does not need to raise additional capital. We assume rising SG&A as the company commercializes its products. We assume an improving cost of goods sold (COGS) over time. Our valuation models: Free Cash Flow to the Firm (FCFF), discounted EPS (dEPS), and Sum-of-the-Parts (SOP), use a 15% discount rate. The result of these three models is then equal-weighted, averaged, and rounded to the nearest whole number to provide a 12-month target price."
Reply
2 1
Report
Zohair Alghamdi
Zohair Alghamdi Aug 03, 2022 3:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What just happened!!? why this is going up so fast?
Reply
1 0
Report
Mary Gershon
Mary Gershon Aug 03, 2022 3:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Earnings day coming up
Reply
2 0
Report
Ole Rii
Ole Rii Aug 01, 2022 10:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Push it up got 7k in this sharamuta
Reply
0 0
Report
Sultan Sa
Sultan Sa Aug 01, 2022 10:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lol, nice name
Reply
0 0
Report
Ole Rii
Ole Rii Aug 01, 2022 10:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Normal habibi
Reply
0 0
Report
Forex Harbingers
ForexHarbingers Jul 17, 2022 11:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Likely long consolidation process until late 2023-early 2024 before we get the rocket. Its time to set and forget and add in on any bottom range extensions.
Reply
2 0
Report
Tony Gentel
Tony Gentel Apr 22, 2022 1:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is bottom Just wait for sky rocket fly
Reply
4 1
Report
Ole Rii
Ole Rii Apr 22, 2022 1:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
And it's not on nasdaq so no danger of it getting delisted :D
Reply
0 0
Report
Steven Pendley
Steven Pendley Apr 20, 2022 4:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This company is going to prosper. just a matter of time.
Reply
4 0
Report
Steven Pendley
Steven Pendley Apr 20, 2022 4:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This company is going to prosper. just a matter of time.
Reply
0 0
Report
Steven Pendley
Steven Pendley Apr 20, 2022 4:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This company is going to prosper. just a matter of time.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email